Latest It Distribution News

Orthocell has appointed its first Canadian distributor for Remplir, its innovative nerve repair device, ahead of an official launch at a major surgical conference in Vancouver. The move marks a significant step in expanding the product’s international footprint.

Vanguard Investments Australia has announced estimated distribution amounts for 20 of its ETFs, with payments scheduled for mid-October 2025. Investors can expect detailed income figures across Australian and international equity and fixed income funds.

Power Minerals confirms a high-grade carbonatite hard rock intrusion at its Santa Anna Rare Earth Elements Project in Brazil, with promising grades and ongoing drilling aimed at defining a maiden resource estimate.

Lefroy Exploration has received the first $1.25 million cash advance from BML Ventures, strengthening its financial position ahead of key development milestones at the Lucky Strike and Burns Central gold projects.

Global X Management (AUS) Limited has released updated estimated distribution amounts for 12 of its ETFs listed on the ASX AQUA Market, covering the September 2025 period. The announcement includes key dates and confirms distribution reinvestment plan eligibility for all funds.

Rio Tinto Limited has updated its dividend reinvestment plan details, announcing a DRP share price of AUD 121.97 and an allocation date of 2 October 2025 for its fully franked interim dividend.

RAM Essential Services Property Fund (REP) reports a Q1 FY26 distribution in line with guidance and reaffirms its full-year yield target while progressing its strategic transition to a healthcare-focused REIT.

Altamin Limited has launched a $6.46 million accelerated entitlement offer to fund exploration at its Lazio and Gorno projects, while excluding shareholders in certain jurisdictions due to regulatory constraints.

CurveBeam AI Limited has secured A$6.5 million in new capital to fuel global growth of its HiRise™ weight-bearing CT scanner, deepen its partnership with orthopaedic giant Stryker, and advance a potential strategic deal in China.

CurveBeam AI has secured A$6.5 million through an institutional placement and completed a €10 million vendor financing facility to accelerate sales of its HiRise™ CT scanner. The company is also progressing a strategic partnership in China and advancing surgical robot validation.

TT Investments, led by 360 Capital’s Executive Chairman Tony Pitt, has launched an unconditional off-market takeover bid for 360 Capital Group at an improved price of A$0.31 per security, signaling potential delisting and operational overhaul.

ReNerve Ltd is rapidly advancing its nerve repair product portfolio, with four ranges expected on the market by the end of 2025 and expanding global distribution. Clinical studies highlight significant patient benefits, supporting the company’s growth in a booming biomaterials market.